Literature DB >> 22744618

Silicate-substituted calcium phosphate ceramic bone graft replacement for spinal fusion procedures.

Vamsi V Nagineni1, Andrew R James, Marjan Alimi, Christoph Hofstetter, Benjamin J Shin, Innocent Njoku, Apostolos John Tsiouris, Roger Härtl.   

Abstract

STUDY
DESIGN: Retrospective study.
OBJECTIVE: To assess the clinical and radiographical outcomes in spinal fusion procedures using silicate-substituted calcium phosphate (Si-CaP). SUMMARY OF BACKGROUND DATA: Si-CaP is a newer-generation synthetic ceramic designed to maximize osteoinduction and osteoconduction.
METHODS: This is a retrospective analysis of a prospectively collected patient database including 108 patients (204 individual spinal levels). Different surgical procedures performed included 25 anterior cervical discectomy and fusions, 17 posterior cervical fusions, 7 combined anterior and posterior cervical fusions, 10 thoracic fusion surgeries, 18 transforaminal lumbar interbody fusions with 12 axial lumbar interbody fusions, 11 transpsoas discectomy and fusions, and 8 combined thoracolumbar fusion procedures. Si-CaP was used as bone extender without any additional graft material, bone marrow aspirate, or bone morphogenetic protein. Clinical outcomes were assessed using the visual analogue scale (VAS), Oswestry Disability Index, and Neck Disability Index. Fusion was determined by the presence of bony bridging on 2 consecutive sections in at least 2 planes on computed tomographic imaging.
RESULTS: At a follow-up of 12 (± 4.7) months, 90% of all patients demonstrated radiographical fusion. Fusion rates were highest in the cervical spine (97%) followed by thoracic and lumbar spines (86% and 81%, respectively). There were significant improvements in all clinical outcome measures-Oswestry Disability Index, 11.1 (± 10.2) and Neck Disability Index, 9.0 (± 11.4); VAS-back, 3.1(± 3.0); VAS-leg, 3.5 (± 3.6); VAS-neck, 3.7 (± 2.5); and VAS-arm 4.0 (± 3.2). There was no radiographical loosening of instrumentation due to infection or nonunion in this series, and no subsequent revisions for nonunion were required.
CONCLUSION: Si-CaP is an alternative to autogenous bone graft in spinal arthrodesis procedures. At 12-month follow-up, we detected high levels of bony fusion using Si-CaP in combination with various surgical spinal techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744618     DOI: 10.1097/BRS.0b013e318265e22e

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

1.  Single-center, consecutive series study of the use of a novel platelet-rich fibrin matrix (PRFM) and beta-tricalcium phosphate in posterolateral lumbar fusion.

Authors:  Tucker C Callanan; Antonio T Brecevich; Craig D Steiner; Fred Xavier; Justin A Iorio; Celeste Abjornson; Frank P Cammisa
Journal:  Eur Spine J       Date:  2018-12-03       Impact factor: 3.134

2.  Preliminary Results of Bioactive Amniotic Suspension with Allograft for Achieving One and Two-Level Lumbar Interbody Fusion.

Authors:  Pierce D Nunley; Eubulus J Kerr; Philip A Utter; David A Cavanaugh; Kelly A Frank; Devan Moody; Brian McManus; Marcus B Stone
Journal:  Int J Spine Surg       Date:  2016-04-18

Review 3.  MIS lateral spine surgery: a systematic literature review of complications, outcomes, and economics.

Authors:  Jeff A Lehmen; Edward J Gerber
Journal:  Eur Spine J       Date:  2015-04-08       Impact factor: 3.134

4.  Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.

Authors:  Abhijeet Kadam; Paul W Millhouse; Christopher K Kepler; Kris E Radcliff; Michael G Fehlings; Michael E Janssen; Rick C Sasso; James J Benedict; Alexander R Vaccaro
Journal:  Int J Spine Surg       Date:  2016-09-22

5.  Evaluation of an increased strut porosity silicate-substituted calcium phosphate, SiCaP EP, as a synthetic bone graft substitute in spinal fusion surgery: a prospective, open-label study.

Authors:  Ciaran Bolger; Drew Jones; Steven Czop
Journal:  Eur Spine J       Date:  2019-03-05       Impact factor: 3.134

6.  Comparison of Silicate-Substituted Calcium Phosphate (Actifuse) with Recombinant Human Bone Morphogenetic Protein-2 (Infuse) in Posterolateral Instrumented Lumbar Fusion.

Authors:  Paul Licina; Marc Coughlan; Emma Johnston; Mark Pearcy
Journal:  Global Spine J       Date:  2015-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.